Pentwater Capital Management LP Repare Therapeutics Inc. Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$25.89 - $44.46 $349,515 - $600,210
-13,500 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$23.42 - $39.5 $117,100 - $197,500
5,000 Added 58.82%
13,500 $463,000
Q3 2020

Nov 16, 2020
SELL
$21.55 - $33.92 $107,750 - $169,600
-5,000 Reduced 37.04%
8,500 $262,000
Q2 2020

Aug 14, 2020
BUY
$30.8 - $32.99 $415,800 - $445,365
13,500 New
13,500 $419,000

Others Institutions Holding RPTX

# of Institutions
62
Shares Held
35.4M
Call Options Held
50K
Put Options Held
300
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $132M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email